Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Nitin RohatgiMichael RothePam K MangatElizabeth Garrett-MayerFunda Meric-BernstamEvan PisickOlatunji B AleseChristopher M ReynoldsRamya ThotaGina M VaccaroMargaret von MehrenRebecca C ArendVi K ChiuHerbert L DuvivierPhilip J GoldKeely HackAlissa S MarrArthur WinerGina N GranthamDominique C HinshawAbigail GregorySusan HalabiRichard L SchilskyPublished in: JCO precision oncology (2023)
mutations.